Peptide record

TPDB11711

Antibacterial Anticancer Antidiabetic Antifungal Antiparasitic Hemolysis Toxicity standard
37 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11711
Antibacterial Anticancer Antidiabetic Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 SATPdb dbACP iACP-DRLF Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 37-aa standard natural multi-activity (Antibacterial, Anticancer, Antidiabetic, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC
Physicochemical Analysis
C173H289N47O47S2
NEHMPTWY
K
3843.60
10.27
7
2
16
+5
3.16
0.373
97.57
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
3.25
7
Residue Composition
number
4
A
1
R
0
N
2
D
2
C
0
E
1
Q
5
G
0
H
2
I
4
L
6
K
0
M
3
F
0
P
4
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 4 R: 1 N: 0 D: 2 C: 2 E: 0 Q: 1 G: 5 H: 0 I: 2 L: 4 K: 6 M: 0 F: 3 P: 0 S: 4 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
37
C173H289N47O47S2
3843.60
10.27
+5
3.16
0.373
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MR
Evidence 2 Activity

Activity

MIC
Antibacterial
5 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP

Other

Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 u
Evidence 3 Activity

Activity

MIC
Antibacterial
5 µM

Target

Klebsiella pneumoniae ATCC 700603

Source & Reference

dbAMP DRAMP

Other

Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 uM), and S. maltophilia (MIC Ojo et al.
Evidence 4 Activity

Activity

MIC
Antibacterial
5 µM

Target

A. baumannii

Source & Reference

dbAMP DRAMP

Other

ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 uM), and S. maltophilia (MIC Ojo et al., 2015 ), thereby of interest for type 2 diabetes (T2D
Evidence 5 Activity

Activity

MIC
Antifungal
5 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MR
Evidence 6 Activity

Activity

MIC
Antifungal
5 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 u
Evidence 7 Activity

Activity

MIC
Antifungal
5 µM

Target

Klebsiella pneumoniae ATCC 700603

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 uM), and S. maltophilia (MIC Ojo et al.
Evidence 8 Activity

Activity

MIC
Antifungal
5 µM

Target

A. baumannii

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 uM), and S. maltophilia (MIC Ojo et al., 2015 ), thereby of interest for type 2 diabetes (T2D
Evidence 9 Activity

Activity

MIC
Antiparasitic
5 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MR
Evidence 10 Activity

Activity

MIC
Antiparasitic
5 µM

Target

Pseudomonas aeruginosa ATCC 27853

Source & Reference

DRAMP

Other

Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 u
Evidence 11 Activity

Activity

MIC
Antiparasitic
5 µM

Target

Klebsiella pneumoniae ATCC 700603

Source & Reference

DRAMP

Other

Active against Bacteria E. coli (MIC 5 uM), P. aeruginosa ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 uM), and S. maltophilia (MIC Ojo et al.
Evidence 12 Activity

Activity

MIC
Antiparasitic
5 µM

Target

A. baumannii

Source & Reference

DRAMP

Other

ATCC 27853 (MIC 5 uM), K. pneumoniae ATCC 700603 (MIC 5 uM), S. aureus (MRSA) (MIC 5 uM), A. baumannii (MIC 5 uM), and S. maltophilia (MIC Ojo et al., 2015 ), thereby of interest for type 2 diabetes (T2D
Evidence 13 Activity

Activity

LC50
Hemolysis
150 µM
[Ref.21262304] LC50=150 µM against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Peptides. 2011 Apr 32(4):664-669.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
150 µM
Hemolytic Cytotoxic
50% Hemolysis | 150 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 15 Activity

Activity

LC50
Toxicity
150 µM
Hemolytic
Hemolytic_activity: [Ref.21262304] LC50=150 µM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2011 Apr 32(4):664-669.
Evidence 16 Hemolysis

Activity

150 µM
LC50
[Ref.21262304] LC50=150 µM against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

APD_complete HemoPI PD_Hemolysis
Peptides. 2011 Apr 32(4):664-669.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.